Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Toxicity Issues Halt PBT1 Program In Alzheimer's; Prana's Stock Falls

April 12, 2005

By Jennifer Boggs

Ambrx Raises $23M Privately To Advance Growth Hormone

April 11, 2005

By Jennifer Boggs

Ambrx Raises $23M Privately To Advance Growth Hormone

April 11, 2005

By Jennifer Boggs

BioMarin Pushes Phenoptin Into Pivotal Program In PKU

April 8, 2005

By Jennifer Boggs

Avanir Raises $17M, Continues Work On Neurodex Rolling NDA

April 8, 2005

By Jennifer Boggs

BioMarin Pushes Phenoptin Into Pivotal Program In PKU

April 8, 2005

By Jennifer Boggs

Avanir Raises $17M, Continues Work On Neurodex Rolling NDA

April 8, 2005

By Jennifer Boggs

License of cancer biomarker to Abbott a BioCurex 'major event'

April 7, 2005

By Jennifer Boggs

Geron, Exeter Form Joint Venture To Exploit Cloning IP From Roslin

April 7, 2005

By Jennifer Boggs

Geron, Exeter Form Joint Venture To Exploit Cloning IP From Roslin

April 7, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...